News

iTeos Therapeutics Inc.: iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates
Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25 - Interim datasets from GALAXIES H&N-202 and TIG-006 HNSCC with ~200 patients anticipated in 2025 - Cash ...
The Manila Times4h
CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting
CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced ...
BERNAMA16h
Carterra Kicks Off 2025 Symposia Series On Advancing Drug Discovery
Carterra Inc, a provider of innovative technologies, is partnering with ImmunoPrecise Antibodies (IPA), ACROBiosystems, and ...
Vietnam Investment Review23h
Innovent Showcases Breakthrough Preclinical Data on Novel Antibodies at AACR 2025
IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 ...
Macau Business23h
2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs
IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 immune checkpoint blockade, enhancing immunogenic cell death and T cell ...